Skip to main content
. Author manuscript; available in PMC: 2023 Jun 6.
Published in final edited form as: Psychol Med. 2021 Dec 6;53(6):2241–2251. doi: 10.1017/S0033291721004037

Figure 1. Timeline of assessments in the UK Biobank.

Figure 1.

*Genetic samples are in green, **medication usage variables are in red, and ***psychiatric phenotypes are in blue. Medication usage was assessed concurrently with the depression phenotypes and 6–10 years prior to the assessment of PTSD.